Dementia News and Research

Latest Dementia News and Research

Intra-Cellular Therapies demonstrates ability of ITI-002 to improve motor and non-motor behaviors in PD

Intra-Cellular Therapies, Inc. today announced results from studies demonstrating the anti-Parkinson and other beneficial effects of ITI-002 (IC200214), the Company's novel and selective phosphodiesterase type I (PDE1) inhibitor.

1 Oct 2010

COE on Brain Aging at NYU Langone establishes Lewy Body Disease Center

The Center of Excellence (COE) on Brain Aging at NYU Langone Medical Center has established a specialty center for the diagnosis and treatment of Lewy Body Disease, a multi-system disease involving disturbances of cognition, behavior, sleep and autonomic function. Lewy Body Disease, or LBD, affects an estimated 1.3 million individuals in the United States and is widely misdiagnosed because LBD symptoms closely resemble those of other more commonly known diseases such as Alzheimer's and Parkinson's disease.

30 Sep 2010

Memantine enhances language and communication skills in patients with Alzheimer's disease

Memantine enhances language and communication skills in patients with moderate to severe Alzheimer’s disease (AD), a valuable contribution for patient independence and quality of life for both the patient and the family/caregivers. These are the findings discussed at the 14th Congress of the European Federation of Neurological Societies (EFNS).

30 Sep 2010

Study indicates majority of children suffering from chronic headache may outgrow the condition

Most children who suffer from chronic daily headache may outgrow the disabling condition, according to research published in the July 15, 2009, online issue of NeurologyÂ®, the medical journal of the American Academy of Neurology.

28 Sep 2010

Family members, friends are more sensitive to early signs of Alzheimer's dementia: Researchers

Family members and close friends are more sensitive to early signs of Alzheimer's dementia than traditional screening tests, according to researchers at Washington University School of Medicine in St. Louis.

28 Sep 2010

Researchers develop STAND-Map framework to promote accurate diagnosis of dementia

A new Mayo Clinic study may help physicians differentially diagnose three common neurodegenerative disorders in the future. The study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 11 in Vienna.

27 Sep 2010

Individuals with growing amount of white matter hyperintensities are more likely to develop dementia

Elderly people with no memory or thinking problems are more likely to later develop thinking problems if they have a growing amount of "brain rust," or small areas of brain damage, according to a study published in the July 14, 2009, print issue of NeurologyÂ, the medical journal of the American Academy of Neurology.

27 Sep 2010

Congress considers setting standards to reduce football concussions

NPR: "A college player who recently committed suicide had a degenerative brain disease normally linked to much older players. It's prompting a new round of questions about safety in the dangerous game that Americans love. ... [Chronic traumatic encephalopathy] is the football concussion 'disease of the moment.' In the past couple of years, Boston University's Center for the Study of Traumatic Encephalopathy has revealed that many deceased NFL players had CTE. The symptoms include depression, erratic behavior and, ultimately, dementia" (Goldman, 9/23).

24 Sep 2010

Concerted effort yields significant progress in reducing depression, HIV/AIDS, and osteoporosis in women

A concerted effort to boost research on women's health over the last two decades has lessened the burden of disease and reduced deaths among women due to cardiovascular disease, breast cancer, and cervical cancer, says a new report from the Institute of Medicine. The effort has yielded less but still significant progress in reducing the effects of depression, HIV/AIDS, and osteoporosis on women, added the committee that wrote the report.

24 Sep 2010

FDA grants clearance for HPβCD treatment for Niemann Pick Type C disease

Children's Hospital & Research Center Oakland announced today that the US Food and Drug Administration (FDA) has granted clearance of an Investigational New Drug (IND) application to introduce Trappsol Cyclo (Hydroxypropyl Beta Cyclodextrin or HPβCD) into the brains of six year old identical twin girls dying of a rare brain-destroying cholesterol disease called Niemann Pick Type C (NPC).

24 Sep 2010

Negative childhood experiences impacting in the brains of Indigenous kids

Australia will not Close the Gap on Aboriginal health unless more is done to reverse the early life stress and trauma experienced by Indigenous children, new research suggests.

23 Sep 2010

Career choice may influence where dementia takes root in the brain: Study

In an international study of patients with a devastating type of dementia that often strikes in middle age, researchers have found intriguing evidence that career choice may influence where the disease takes root in the brain.

23 Sep 2010

People's Care ranks #2140 on Inc. 5000 list of fastest growing private companies

Inc. Magazine included Southern California-based People's Care in its fourth annual Inc. 5000, an exclusive ranking of the country's fastest growing private companies. The list represents a comprehensive look at an important segment of the United States' economy: independent entrepreneurs. People's Care joins other prominent brands on the list, including music website Pandora, 7-Eleven and Radio Flyer.

23 Sep 2010

Rush University researchers identify potential new way to prevent Alzheimer's disease progression

Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.

22 Sep 2010

ADI releases World Alzheimer Report 2010

The World Alzheimer Report 2010 was released today to mark World Alzheimer's Day and heighten awareness of the global economic impact of Alzheimer's disease and related dementias.

21 Sep 2010

Ginkgo-special extract improves mental performance of dementia patients

In a systematic review, known as a meta-analysis, a group of scientists at the University of Shanghai has demonstrated yet again that Ginkgo-special extract EGb 761 significantly improves the mental performance of dementia patients (Wang et al., 2010). A particular feature of this review was that, for the first time, researchers incorporated the risk of further deterioration of mental performance due to the natural progress of the disease into their assessment.

21 Sep 2010

Global dementia costs hit $604 billion: World Alzheimer Report 2010

The total estimated worldwide costs of dementia are $604 billion in 2010, according to the newly released World Alzheimer Report 2010, The Global Economic Impact of Dementia from Alzheimer's Disease International (ADI), a London based, nonprofit, international federation of 73 national Alzheimer organizations, including the Alzheimer's Association (U.S.).

21 Sep 2010

Alzheimer's disaster is no longer 'emerging'

Tomorrow on World Alzheimer's Day, the Alzheimer's Association recognizes the efforts of the Obama Administration for bringing stakeholders to the table to begin an important dialogue on how best to address the Alzheimer epidemic. The meeting will include representatives of the Alzheimer community, policymakers from across the federal government, Alzheimer researchers, people with Alzheimer's and care providers to exchange objectives and strategies on how to overcome the growing Alzheimer epidemic.

21 Sep 2010

Global action needed to address 'most significant health crisis of the 21st century'

A landmark report on the Global Economic Impact of Dementia finds that Alzheimer's disease and other dementias are exacting a massive toll on the global economy, with the problem set to accelerate in coming years. The World Alzheimer Report 2010 - issued on World Alzheimer's Day by Alzheimer's Disease International (ADI) - provides the most current and comprehensive global picture of the economic and social costs of the illness.

21 Sep 2010

URB937 drug boosts natural painkiller level: Study

A new study has shown how a novel compound boosts levels of a natural painkiller at the site of an injury. The ground-breaking study published today in Nature Neuroscience shows how the potential drug URB937 acts in peripheral tissue and may have the potential to relieve pain without the side effects associated with many current painkillers that act centrally on the nervous system.

20 Sep 2010

Dementia News and Research

Latest Dementia News and Research

Intra-Cellular Therapies demonstrates ability of ITI-002 to improve motor and non-motor behaviors in PD

COE on Brain Aging at NYU Langone establishes Lewy Body Disease Center

Memantine enhances language and communication skills in patients with Alzheimer's disease

Study indicates majority of children suffering from chronic headache may outgrow the condition

Family members, friends are more sensitive to early signs of Alzheimer's dementia: Researchers

Researchers develop STAND-Map framework to promote accurate diagnosis of dementia

Individuals with growing amount of white matter hyperintensities are more likely to develop dementia

Congress considers setting standards to reduce football concussions

Concerted effort yields significant progress in reducing depression, HIV/AIDS, and osteoporosis in women

FDA grants clearance for HPβCD treatment for Niemann Pick Type C disease

Negative childhood experiences impacting in the brains of Indigenous kids

Career choice may influence where dementia takes root in the brain: Study

People's Care ranks #2140 on Inc. 5000 list of fastest growing private companies

Rush University researchers identify potential new way to prevent Alzheimer's disease progression

ADI releases World Alzheimer Report 2010

Ginkgo-special extract improves mental performance of dementia patients

Global dementia costs hit $604 billion: World Alzheimer Report 2010

Alzheimer's disaster is no longer 'emerging'

Global action needed to address 'most significant health crisis of the 21st century'

URB937 drug boosts natural painkiller level: Study

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Dementia News and Research

Latest Dementia News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in